FRPH NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Frp Holdings Ord · Real Estate · Real Estate Services

Open interactive chart View report data
Latest close 22.32 USD
-4.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is -3.4% below the Trend Line and sits at 27.7% of its 52-week range. The latest completed week returned -4.7%, after a -11.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 48/100. Near-term considerations: earnings are due in 2d.

Setup score 36 out of 100
Latest Close 22.32 USD 31 Jul 2026
1W Return -4.7% latest completed week
4W Return -11.8% short-term follow-through
12W Return 5.6% quarterly tape
Trend Breadth 9.6% 5 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.7% Latest completed week; four-week move -11.8%. Indicator stack 23/57 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 48/100 24 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is -3.4% below the Trend Line and sits at 27.7% of its 52-week range. The latest completed week returned -4.7%, after a -11.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5412-week average 0.25

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.54Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -11.8% over four weeks, 5.6% over 12 weeks, and -14.0% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-4.7%
4W-11.8%
12W5.6%
26W-6.6%
52W-14.0%
Active trend streak5 weeks
Active weeks in one year5
Trend breadth9.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.60Latest activity-pressure read.
Pressure change-51.9%Four-week change in activity pressure.
Leadership-13.78Latest relative-leadership reading.
RS change-65.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength5/100Blend of value, momentum, and quality. Underlying universe rank 96; rank 1 is best.
Value15/100Relative valuation strength. Underlying universe rank 86; rank 1 is best.
Quality25/100Profitability and accounting quality. Underlying universe rank 76; rank 1 is best.
Momentum20/100Medium-term price momentum. Underlying universe rank 81; rank 1 is best.
Growth2/100Revenue and earnings growth. Underlying universe rank 99; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
481.2x
Price divided by trailing earnings.
Price / sales
10.4x
Market value relative to trailing revenue.
EV / EBITDA
41.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
27.2%
Gross profit retained from each unit of revenue.
Operating margin
6.3%
Operating profit retained from revenue.
Free-cash-flow margin
150.7%
Free cash flow generated from revenue.
Return on invested capital
0.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.8%
Latest one-year revenue growth.
EPS growth
-86.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
112.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.1%
Net share repurchases relative to market value.
Shareholder yield
0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
6.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment48/100

Weighted news tone is neutral across 24 relevant articles.

0 positive · 21 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.3%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+7.0%Week of 26 Jun.
Worst week-7.9%Week of 20 Mar.
Latest week-4.7%Week of 31 Jul.

Shape of recent returns

Strong gains1
Modest gains12
Flat weeks0
Modest losses10
Sharp losses3
Recent vol3.2%13-week weekly-return volatility.
Base vol2.9%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew2.1% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis44/100

Latest 12-week confirmation: trend 5/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.54; No reversal markers Factors15/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 41; Small Cap Core rank 91 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment48/100

Weighted news tone is neutral across 24 relevant articles.

Understanding Momentum Shifts in (FRPH) Insiders6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202622.32 USD-4.7%23.10 USD27.32 USD0.60-13.78403.8KOn
24 Jul 202623.42 USD-2.5%23.11 USD27.36 USD0.85-9.71429.3KOn
17 Jul 202624.03 USD0.2%23.09 USD27.39 USD1.09-9.48254.7KOn
10 Jul 202623.98 USD-5.3%23.03 USD27.42 USD1.17-14.01256.8KOn
3 Jul 202625.31 USD-0.3%23.01 USD27.45 USD1.25-8.33201.6KOn
26 Jun 202625.38 USD7.0%22.94 USD27.47 USD1.15-7.91542.0KOff
19 Jun 202623.72 USD-0.3%22.87 USD27.49 USD0.82-18.39205.1KOff
12 Jun 202623.79 USD1.1%22.86 USD27.52 USD0.63-16.73254.1KOff
5 Jun 202623.54 USD1.9%22.88 USD27.55 USD0.36-16.44246.2KOff
29 May 202623.11 USD2.1%22.87 USD27.59 USD-0.04-22.32266.2KOff
22 May 202622.63 USD3.1%22.89 USD27.63 USD-0.40-22.51440.0KOff
15 May 202621.94 USD3.8%22.97 USD27.66 USD-0.72-24.70732.1KOff
8 May 202621.14 USD0.6%23.08 USD27.70 USD-0.82-28.35326.1KOff
1 May 202621.02 USD-2.6%23.18 USD27.74 USD-0.69-25.76217.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.